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Abstract
Purpose The purpose of this study was to assess test–retest reliability, agreement, and responsiveness of questionnaires 
on productivity loss (iPCQ-VR) and healthcare utilization (TiCP-VR) for sick-listed workers with chronic musculoskeletal 
pain who were referred to vocational rehabilitation. Methods Test–retest reliability and agreement was assessed with a 
2-week interval. Responsiveness was assessed at discharge after a 15-week vocational rehabilitation (VR) program. Data 
was obtained from six Dutch VR centers. Test–retest reliability was determined with intraclass correlation coefficient (ICC) 
and Cohen’s kappa. Agreement was determined by Standard Error of Measurement (SEM), smallest detectable changes (on 
group and individual level), and percentage observed, positive and negative agreement. Responsiveness was determined with 
area under the curve (AUC) obtained from receiver operation characteristic (ROC). Results A sample of 52 participants on 
test–retest reliability and agreement, and a sample of 223 on responsiveness were included in the analysis. Productivity loss 
(iPCQ-VR): ICCs ranged from 0.52 to 0.90, kappa ranged from 0.42 to 0.96, and AUC ranged from 0.55 to 0.86. Healthcare 
utilization (TiCP-VR): ICC was 0.81, and kappa values of the single healthcare utilization items ranged from 0.11 to 1.00. 
Conclusions The iPCQ-VR showed good measurement properties on working status, number of hours working per week 
and long-term sick leave, and low measurement properties on short-term sick leave and presenteeism. The TiCP-VR showed 
adequate reliability on all healthcare utilization items together and medication use, but showed low measurement properties 
on the single healthcare utilization items.
Keywords Productivity loss · Healthcare utilization · Vocational rehabilitation · Cost-effectiveness · Measurement 
properties
Introduction
Chronic musculoskeletal pain (CMP) is a common condi-
tion that results in major disability and substantial health-
care costs [1, 2]. CMP has a negative impact on performing 
work, resulting in productivity loss from work; reflected 
by absenteeism (sick off work) or presenteeism (productiv-
ity loss while at work) [3]. Productivity loss is labeled in 
cost-effectiveness studies as indirect healthcare costs [4]. 
Direct health costs are intervention costs, traveling costs and 
healthcare utilization costs. Vocation rehabilitation (VR) 
showed (cost-)effective in improving absenteeism and pres-
enteeism and the reduction of healthcare utilization [5–7].
For clinical practice and research purposes, data about the 
(cost-)effectiveness of VR interventions are often collected 
with patient-reported outcome measures (PROMS). PROMS 
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are standardized, validated questionnaires that are completed 
by patients to measure their perceptions of their functional 
status and wellbeing [8]. To give reliable statements on the 
(cost-)effectiveness of VR, PROMS on productivity loss 
and healthcare utilization must show adequate measurement 
properties [3, 8].
However, currently there are no gold standards available 
for the assessment of productivity loss [9–12]. Evidence on 
retest reliability and responsiveness on PROMS on absentee-
ism is scarce [13] and shows mixed results [11]. Research 
on retest reliability of five presenteeism questionnaires 
showed moderate to sufficient retest reliability in a sample 
with rheumatic diseases (ICCs 0.59–0.78) [10], and low 
to moderate responsiveness in a sample with rheumatoid 
arthritis or osteoarthritis [14]. However, some issues with 
presenteeism questionnaires are prominent; they have dif-
ferent recall periods, different outcome scales (0–10 or 1–7), 
are developed for different populations (general or sickness-
specific, for example rheumatic diseases), and they measure 
different concepts of presenteeism, for example productivity, 
performance or ability [10]. As a consequence, the correla-
tion between global measures of presenteeism is low, which 
complicates comparison [10].
Two Dutch questionnaires on the assessment of pro-
ductivity loss and healthcare utilization have recently been 
developed. These questionnaires are recommended by the 
Dutch guideline for health economic evaluations [4]. The 
questionnaire on the measurement of productivity loss is 
called the iMTA Productivity Cost Questionnaire (iPCQ) 
[11, 15–17] and the questionnaire on the assessment of 
healthcare utilization is called the Trimbos iMTA question-
naire for measuring Costs of Psychiatric Illnesses (TiC-P, 
part I) [18]. In addition, the TiC-P consists of two parts, a 
healthcare usage part (part I) and a productivity loss part 
(part II). Part II has been further developed for the general 
population and resulted in the iPCQ. In a sample with mental 
problems, the TiC-P (parts I and II) showed sufficient feasi-
bility and construct validity, and low to sufficient retest reli-
ability [18]. In another study, the feasibility and face validity 
of the iPCQ was confirmed [15].
However, the iPCQ and TiC-P questionnaires are not fully 
applicable for sick workers with CMP who are referred to 
VR. For example, a large portion of sick workers referred to 
VR are on part-time sick leave and thus part-time at work. 
The iPCQ, however, does not measure part-time work/sick 
leave. Furthermore, the TiC-P questionnaire contains many 
items about mental healthcare but, for example, no items 
about workplace adaptations or visits of reintegration spe-
cialists. Therefore, we modified the iPCQ and TiCP ques-
tionnaires to enhance feasibility and usefulness. We called 
these modified versions the TiCP-VR and the iPCQ-VR. The 
aim of this study is to assess the test–retest reliability, agree-
ment and responsiveness of the iPCQ-VR and TiCP-VR in 
workers with chronic musculoskeletal pain and referred to 
VR in the Netherlands.
Methods
The COnsensus-based Standards for the selection of health 
Measurement INstruments (COSMIN) checklist was applied 
in the design of the study [19].
Procedures
For this study we used two study samples. The first study 
sample was used to perform the retest reliability and agree-
ment analysis, the second study sample was used to perform 
the responsiveness analysis. Participants of the first sam-
ple were recruited from six VR centers in the Netherlands 
(Rijndam, MRC Doorn, Klimmendaal, Trappenberg, UMCG 
CvR and Heliomare). At baseline (T0), patients completed 
the iPCQ-VR, TiCP-VR and other web-based questionnaires 
at home as part of care as usual [20]. After a multidiscipli-
nary screening, eligible patients were informed about the 
study by a member of the multidisciplinary screening team 
and written information describing the study was provided. 
2 weeks after T0, respondents received the iPCQ-VR and 
TiCP-VR for the second time (T1). If T0 was more than 
2 weeks before granted informed consent, the T0 and T1 
questionnaires were sent with 2 weeks in between. If partici-
pants did not complete the T0 or T1 questionnaires within a 
week, they received a reminder email. If the questionnaires 
were not completed after this reminder, participants were 
phoned by the first author TB. Data of study sample 2 was 
derived from routinely collected data from six Dutch reha-
bilitation centers (Heliomare, Roessingh, Adelante, Libra, 
Klimmendaal, Trappenberg), all offering a multidisciplinary 
VR program (15-week duration) for workers with chronic 
musculoskeletal pain. We used baseline (T0) and discharge 
data (T2). The T2 questionnaires were automatically sent 14 
weeks after the start of the VR program. Figure 1 shows the 
measurement points of samples 1 and 2.
Participants
The inclusion criteria were: (1) being of working age 
(18–65 years); (2) suffering from subacute (6–12 weeks) or 
chronic (> 12 weeks) nonspecific musculoskeletal pain such 
as back, neck, shoulder, widespread pain, Whiplash Associ-
ated Disorder (WAD I or II), or fibromyalgia; (3) having paid 
work (employed or self-employed) for at least 12 h per week; 
(4) having sick leave (part-time or full-time); (5) being able 
to complete questionnaires in Dutch; (6) having an email 
address; and (7) having granted informed consent. The 
exclusion criterion was having comorbidities that were the 
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primary reason for sick leave, such as acute or specific medi-
cal problems, clinical depression or burnout, severe asth-
matic symptoms, diagnosed chronic fatigue, and neuropathy. 
The Medical Ethical Committee of the Academic Medical 
Center, Amsterdam, the Netherlands, authorized this study 
and decided that a full application was not required. Partici-
pation in the study was voluntary, all participants provided 
informed consent and answers were processed anonymously.
Measurements
Patient Characteristics
Several demographic and clinical variables were assessed 
at baseline: age, gender, education, pain features (location, 
duration and intensity), work features (status, contract), and 
level of disability.
iPCQ-VR
The iPCQ-VR is a modified version of the iPCQ [11, 15, 17, 
18], and is used by six VR centers in the Netherlands. The 
iPCQ-VR adopted the absenteeism and presenteeism mod-
ules of the original iPCQ [17], and two extra modules were 
added: working status and pain-specific sick leave. We pilot-
tested preliminary versions within our research team and 
four patients pilot-tested the pre-final version of the ques-
tionnaire. All items of the iPCQ-VR and the corresponding 
rating scales are shown in Online Appendix 1.
TiCP-VR
The original TiC-P assesses the visits and consultation of 
several healthcare providers, and medication use [18]. The 
utilization of each healthcare provider is assessed with a yes/
no item and if patients answer ‘yes’, the number of visits/con-
sultations is assessed. A recall period of 4 weeks is used in 
the original questionnaire, which we adopted in the TiCP-VR 
version. In the TiCP-VR version, we removed five items that 
were specific to psychiatric patients, but not for our population. 
Furthermore, we added pain-specific items to allow differen-
tiation between pain-related and other healthcare utilization. 
Finally, we removed non pain-related medication use. This was 
due to feasibility reasons and it was expected that medication 
use other than pain-related was marginal when translated to 
costs. Also, it was expected that this adaptation would prevent 
missing data on medication use, as this was prominent in the 
original TiC-P validation study [18]. We pilot-tested prelimi-
nary versions within our research team and four patients pilot-
tested the pre-final version of the questionnaire. All items of 
the TiCP-VR and the corresponding rating scales are shown 
in Online Appendix 2.
Global Perceived Effect
One global perceived effect (GPE) item (‘How much did the 
vocational rehabilitation program change your work function-
ing compared to pre-treatment level?’) was assessed at T2 and 
was used as the external criterion (anchor) in the responsive-
ness analysis in this study. GPE was measured with a 7-point 
Likert scale ranging from 1 to 7 (1; ‘extremely worsened’, 
2; ‘much worsened’, 3; ‘little worsened’, 4; ‘unchanged’, 5; 









Start VR Discharge VR
Week 1 Week 14 Week 15
Fig. 1  Measurement points of this study. VR vocational rehabilitation, Sample 1: assessment of test–retest reliability and agreement, Sample 2: 
assessment of responsiveness




Test–retest reliability of the continuous items of the iPCQ-
VR were performed with intraclass correlation coefficient 
(ICC random, single, and on absolute agreement) [21]. To 
allow comparison with other studies, in particular the origi-
nal iPCQ study by Bouwmans et al. [18], we performed sen-
sitivity analyses with ICC random, average, and on absolute 
agreement. One overall ICC of all healthcare visits/consulta-
tions of TiCP-VR together was calculated because the single 
continuous items were expected to be underpowered [18].
We considered an ICC of > 0.70 sufficient for use at group 
level and an ICC of > 0.90 sufficient for use at individual 
level [22].
Reliability of dichotomous items of iPCQ-VR and 
TiCP-VR were studied using Cohen’s kappa analyses [
k = Po − Pc∕1 − Pc
]
 where Po is the proportion of observed 
agreements and Pc is the proportion of agreements expected 
by chance [23]. The range of possible values of kappa is 
from − 1 to 1 [23]. We interpreted kappa values as follows: 
slight (0.00–0.20), fair (0.21–0.40), moderate (0.41–0.60), 
substantial (0.61–0.80) and almost perfect (0.81–1.00) [24]. 
The pain-specific items of the TiCP-VR were expected to be 
underpowered and were blended to one 2 × 2 contingency 
table.
Reliability of categorical variables was performed with 
linear weighted kappa coefficients [25, 26].
Agreement
Agreement of continuous variables was analyzed by the 
standard error of measurement [SEM = SD
√
1 − ICC] , 
where SD is the SD of the scores from all participants, 
which were determined from an ANOVA analysis with 
the formula [
√
SStotal ∕(n − 1)] , and ICC is the retest 
reliability coefficient [21]. The SEM was converted 





2 × SEM] . This number reflects 
the smallest within-person change in a score that can be 
considered to be a real change above any measurement error 
within one individual. The SDC individual was converted 
into the SDC for a group (SDC group) by dividing the SDC 
individual by √n. We proposed a positive rating for agree-
ment if the absolute measurement error (SDC individual 
for change within individuals and SDC group for change 
between groups) is smaller than the minimal important 
change (MIC, see responsiveness) [27, 28].
Agreement of dichotomous variables was analyzed by the 
percentage observed agreement [P
o
= (a + d)∕n] , the per-
centage positive agreement [PA = 2a∕2a + b + c] , and the 
percentage negative agreement [NA = 2d∕2d + b + c] [29]. 
PA is known as the specific agreement on a positive rating 
and NA is known as the specific agreement on a negative 
rating [29]. All 2 × 2 contingency tables will be provided 
in Online Appendices 3 and 4. Categorical variables were 
analyzed by the percentage observed agreement.
Responsiveness
Responsiveness in this study was defined as the ability of 
the iPCQ-VR to detect clinically relevant changes over 
time [27]. We assessed the responsiveness on four continu-
ous items: the number of sick leave days in the preceding 4 
weeks (for participants with short-term sick leave at T0), 
the number of working hours per week (for participants 
with 100% sick leave at T0), the number of presenteeism 
days in the preceding 4 weeks and the presenteeism score 
(0–10) (for participants who scored ‘yes’ on presentee-
ism at T0). Various statistics were applied to calculate 
responsiveness [30]. Mean changes and 95% confidence 
intervals of mean changes were calculated. Sensitivity and 
specificity for change plotted by receiver operating char-
acteristic (ROC) curve and area under the curves (AUCs) 
were calculated [31]. The AUC is the probability of cor-
rectly discriminating between improved and nonimproved 
patients. When the AUC was more than 0.70, responsive-
ness was considered sufficient [27]. MIC was measured 
by determining the optimal cut-off point (OCP). This is 
the point of the ROC curve where the sum of sensitivity 
and 1-specificity is maximal. Sensitivity and specificity of 
the OCP were computed. Sensitivity and specificity range 
from 0 to 1.00, where higher numbers reflect higher sen-
sitivity or specificity. Because the objective of the respon-
siveness analysis was to differentiate between improved 
and unchanged samples of participants, the GPE score was 
dichotomized into a subgroup with GPE score “improved” 
(little improved, much improved and completely improved) 
and a subgroup with the GPE score “unchanged”. The GPE 
group “worsened” was not included in the analyses [30].
Stability
The ICC, kappa, and agreement analyses were performed 
on a stable sample that completed the questionnaire twice 
in similar conditions, with a 2-week interval. To perform 
this, we added external anchor items at T1 (external anchor 
item: ‘In relation to question x, did something change in 
the preceding 2 weeks, compared to the weeks before?’). 
To allow comparison with other studies, results of both 
stable and unstable (i.e. total sample) retest samples will 
be reported.
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We applied an online calculation tool to calculate kappa 
and linear weighted kappa [32]. All other analyses were 
performed using SPSS 23 for Windows (SPSS Inc., Chi-
cago, USA). The demographic data of the individuals were 
described by means and standard deviations (SD), or inter-
quartile range in the case of no normal distribution. The 
assumption of normal data distribution was visually verified 
using histograms and QQ-plots.
Power
Fifty patients are needed to obtain a reasonable 2 × 2 con-
tingency table to determine the kappa and to obtain a con-
fidence interval ranging from 0.70 to 0.90 around an ICC 
of 0.80 [12, 24, 27]. 50 to 99 patients are needed to obtain 
reasonable responsiveness scores [33].
Results
A total of 52 participants completed the retest questionnaires 
(response rate retest 71%). Reasons for non-response were 
technical problems (n = 7), withdrawal consent (n = 3), no 
telephone number (n = 2), or unknown (n = 9). The retest was 
submitted on average 19.6 days (SD 5.8) after submission 
of the initial questionnaires. A sample of 223 participants 
completed baseline and discharge responsiveness question-
naires. Response rates of this sample were unknown. The 
responsiveness questionnaires were submitted on average 
14.5 weeks (SD 1.0) after T0. Table 1 shows the character-
istics of both study samples.
Reliability
The ICCs of the iPCQ-VR ranged from 0.52 to 0.90 
(Table 2). Number of working hours per week scored 0.90, 
number of short-term sick leave days scored 0.54, presen-
teeism score scored 0.56, and number of presenteeism days 
scored 0.52. The ICC of total healthcare utilization was 0.81. 
Sensitivity analysis with average measures of ICC showed 
the following ICCs: number of working hours (0.95), pres-
enteeism score (0.72), number of presenteeism days (0.68), 
number of sick leave days (0.70), and total healthcare utili-
zation (0.89).
Cohen’s kappa of the iPCQ-VR ranged from 0.42 to 0.96 
(Table 2). In the total (both stable and unstable participants) 
sample, long-term pain-specific sick leave scored a kappa of 
1.00 (Table 3). Cohen’s kappa items of the healthcare utili-
zation items of the TiCP-VR ranged from 0.11 to 1 (Table 4). 
Medication use showed substantial kappa (0.78) and total 
pain-specific healthcare utilization showed fair kappa (0.35). 
Table 5 shows kappa and agreement measures of the total 
sample on the TiCP-VR items. Online Appendix 3 (iPCQ-
VR) and Online Appendix 4 (TiCP-VR) show all 2 × 2 con-
tingency tables of both stable and unstable (total) samples.
Table 1  Characteristics of the study populations
SD standard deviation, IQR interquartile range
a 0 = no pain, 10 = worst possible pain








Mean (SD) or %
Age (years) 44.6 (10.3) 47.4 (10.9)









 Disability benefit 3.9 1.4
 Housewife/houseman 2.0 1.4
 Incapacitated 2.0 0.9
Contract (hours/week) 32.8 (7.0) 31.3 (8.8)
Contract (days/week) 4.3 (1.1) 4.2 (1.0)
Work status
 Working full-time 14.0 8.5
 Working part-time 58.0 52.6
 100% sick leave 28.0 39.0
Sick leave short (% yes) 50 62
Sick leave long (% yes) 36 49.8
Presenteeism (% yes) 74 63.8
Pain location
 Spine (% yes) 69.2 76.7
 Lower extremities (% yes) 32.7 35.0
 Upper extremities (% yes) 42.3 45.3
Headache/burnout 30.8 40.8
Number of pain locations (IQR) 2 (1–4) 2 (1–4)
Pain duration
 1–3 months 9.6 8.6




 More than 5 years 13.5 18.0
Pain mean (0–10)a 6.0 (1.9) 5.5 (2.3)
Pain worse (0–10)a 7.4 (1.9) 6.9 (2.5)
Pain disability index (0–70)b 37 (12.1) 34.3 (11.6)
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Table 2  ICC, kappa and agreement of the iPCQ-VR in a stable group of participants
NA not applicable
a Linear weighted kappa
b In the case of part-time working (one of the three ‘working status’ options)
c One extreme outlier (value 49) was excluded from the analysis










Yes (N) ICC single (95% CI)
Work status
 Working status 98 NA NA 0.96 (0.88–1)a 41 –
 Number of hours working per  weekb – – – – 16 0.90 (0.74–0.96)
Sick leave short (< 4 weeks)
 Sick leave during last 4 weeks 72 71 73 0.45 (0.19–0.70) 16 –
 Number of sick leave days – – – – 16 0.54 (0.05–0.81)c
 Sick leave pain-specific 94 96 80 0.76 (0.32-1) 13 –
Sick leave long (> 4 weeks)
 Sick leave longer than 4 weeks 88 83 91 0.74 (0.54–0.94) 15 –
 Sick leave pain-specific NA NA NA NA 14 –
Presenteeism (< 4 weeks)
 Presenteeism during last 4 weeks 74 80 62 0.42 (0.13–0.72) 22 –
 Number of presenteeism days – – – – 23 0.52 (0.14–0.76)
 Score of 0–10 – – – – 23 0.56 (0.21–0.79)
Healthcare  usaged NA NA NA NA 37 0.81 (0.66–0.89)
Table 3  ICC, kappa and agreement of the iPCQ-VR in total sample (stable and unstable participants)
NA not applicable
a Linear weighted kappa
b In the case of part-time working (one of the three ‘working status’ options)

















 Working status 86 NA NA 0.80 (0.65–0.94)a 50 –
 Working part-time: number of hours 
working per  weekb
– – – – 24 0.76 (0.52–0.89)
Sick leave short (< 4 weeks)
 Sick leave during last 4 weeks 72 71 73 0.44 (0.19–0.69) 17 –
 Number of sick leave days – – – – 16 0.54 (0.05–0.81) c
 Sick leave pain-specific 94 80 97 0.77 (0.34–1.00) 14 –
Sick leave long (> 4 weeks)
 Sick leave longer than 4 weeks 88 83 91 0.74 (0.54–0.94) 15 –
 Sick leave pain-specific 100 100 100 1.00 (1.00–1.00) 14 –
Presenteeism (< 4 weeks)
 Presenteeism during last 4 weeks 76 83 60 0.43 (0.17–0.70) 29 –
 Number of presenteeism days – – – – 29 0.51 (0.18–0.74)
 Score of 0–10 – – – – 29 0.54 (0.22–0.75)
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Table 4  Kappa and agreement of the TiCP-VR in a stable group of participants
NA not applicable, PT, ET, OT, MT physical therapist, exercise therapist, occupational therapist, manual therapist
a Linear weighted kappa
b The sum of all pain-specific healthcare usage items
N Use of ser-
vice (N)













01 General practitioner 46 9 17 56 57 63 0.13 (0–0.42)
02 PT, ET, OT, MT 42 16 16 76 86 76 0.55 (0.31–0.79)
03 Occupational physician 43 18 6 56 65 39 0.11 (0–0.41)
04 Reintegration specialist 44 6 32 86 67 91 0.59 (0.28–0.89)
05 Insurance physician 49 0 47 96 NA 98 NA
06 Workplace adaptations 48 6 35 85 63 91 0.54 (0.23–0.86)
07 Medical specialist 46 6 31 80 57 87 0.45 (0.12–0.77)
08 Stay in healthcare setting 50 0 50 100 NA 100 NA
09 Psychiatrist or psychologist 47 5 31 76 48 85 0.35 (0–0.68)
10 Social worker 49 0 48 98 NA 99 NA
11 Dietician 49 1 48 100 100 100 1
12 Home care 49 0 48 98 NA 99 NA
13 Alternative care 48 3 41 92 60 95 0.56 (0.14–0.97)
14 Medication use 38 21 13 89 91 87 0.78 (0.58–0.98)
Medication use pain-specific 27 14 2 59 NA NA 0.31 (0–0.66)a
Healthcare usage pain-specificb 50 70 3 89 94 40 0.35 (0–0.75)
Table 5  Kappa and agreement of the TiCP-VR in total sample (stable and unstable participants)
NA not applicable, PT, ET, OT, MT physical therapist, exercise therapist, occupational therapist, manual therapist
a Linear weighted kappa
b The sum of all pain-specific healthcare usage items
N Use of ser-
vice (N)













01 General practitioner 50 12 18 60 55 64 0.21 (0–0.48)
02 PT, ET, OT, MT 50 23 16 78 81 74 0.57 (0.35–0.80)
03 Occupational physician 50 19 7 52 61 59 0.04 (0–0.32)
04 Reintegration specialist 49 9 33 86 72 90 0.63 (0.37–0.88)
05 Insurance physician 50 0 47 94 na 97 NA
06 Workplace adaptations 50 7 35 84 64 90 0.53 (0.24–0.83)
07 Medical specialist 50 8 33 82 44 88 0.52 (0.24–0.80)
08 Stay in health care setting 50 0 50 100 na 100 NA
09 Psychiatrist or psychologist 50 7 31 76 54 84 0.40 (0.10–0.69)
10 Social worker 49 0 48 98 na 99 NA
11 Dietician 49 1 48 100 100 100 1
12 Home care 49 0 48 98 na 99 NA
13 Alternative care 49 4 41 92 67 95 0.62 (0.27–0.98)
14 Medication use 48 30 13 90 92 84 0.76 (0.56–0.96)
Medication use pain specific 30 17 2 63 NA NA 0.36 (0.05–
0.68)a
Health care usage pain  specificb 50 74 4 82 90 32 0.23 (0–0.56)
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Agreement
For the continuous items of the iPCQ-VR, the SEM, 
SDCind and SDCgrp were respectively 0.8, 2.3, 0.6 (num-
ber of working hours per week), 3.6, 10.1, 2.5 (number 
of sick leave days), 2.8, 7.9, 1.6 (number of presenteeism 
days), 0.7, 2.0, 0.4 (presenteeism score) (Table 6).
For the dichotomous items, observed agreement of the 
iPCQ-VR ranged from 72 to 98%, positive agreement ranged 
from 71 to 96% and negative agreement ranged from 62 
to 91% (Table 2). Observed agreement (OA) of the health-
care items of the TiCP-VR ranged from 56 to 100%, posi-
tive agreement (PA) ranged from 48 to 100%, and negative 
agreement (NA) ranged from 39 to 100% (Table 4). Medica-
tion use scored OA: 89%, PA: 91%, NA: 87%. Pain-specific 
medication use (categorical item) scored OA: 59%. All pain-
specific healthcare items together scored OA: 89%, PA: 94%, 
NA: 40%.
Responsiveness
The AUC, MIC, sensitivity and specificity of the iPCQ-VR 
are presented in Table 6 and the ROC curves are shown in 
Fig. 2. The AUCs ranged from 0.55 to 0.86. The number 
of working hours per week showed adequate responsive-
ness for the participants who were on 100% sick leave at 
baseline (AUC 0.86, MIC = − 1). Sick leave days in the 
preceding 4 weeks showed moderate responsiveness (AUC 
0.66, MIC = 5.5). Presenteeism days in the preceding 4 
weeks showed poor responsiveness (AUC 0.55, MIC = 4.5). 
Presenteeism score showed moderate responsiveness (AUC 
0.60, MIC = − 0.5 to − 1.5). Table 7 shows the mean change 
scores of the iPCQ-VR.
Discussion
In this study, the retest reliability, agreement and respon-
siveness of two modified questionnaires on productivity loss 
(iPCQ-VR) and healthcare utilization (TiCP-VR) for work-
ers on sick leave due to chronic musculoskeletal pain and 
referred to VR was assessed.
iPCQ‑VR
The working status and number of working hours per week 
items scored high on retest reliability, agreement, and 
responsiveness. These items can be used at the group and 
individual levels as well as for evaluative purposes. Long-
term sick leave scored sufficient retest reliability and agree-
ment and can be used at group level. Short-term sick leave 
and presenteeism scored low retest reliability, agreement and 
responsiveness, and can therefore not be used at the group 
or individual level, or for evaluative purposes.
Reliability
Comparing the retest reliability of the absenteeism items of 
the current study with the original study [18] is complicated, 
because the original study used average measures ICC,1 
which results in higher ICCs. In our opinion, single meas-
ures ICC is the appropriate ICC to answer the research ques-
tion on retest reliability because in clinical practice patients 
complete the iPCQ-VR once per measurement point (i.e. at 
baseline, discharge, follow-up). Furthermore, the original 
study measured short-term sick leave with a recall period of 
2 weeks, whereas we applied 4 weeks. Finally, the original 
study did not select a stable group of participants.
Table 6  Responsiveness iPCQ-VR
a Available from the SDs and ICCs of sample I
b Selection of participants who were on 100% sick leave at T0 and who reported stable or improved work functioning at T2
c Selection of participants who were on short-term sick leave at T0 and who reported stable or improved work functioning at T2
d Selection of participants who scored ‘yes’ on presenteeism at T0 and who reported stable or improved work functioning at T2
Variable N anchor AUC (CI) MIC Sens Spec SEMa SDCinda SDCgrpa
Working  hoursb 49 positive
22 negative
0.86 (0.77–0.94) − 1 0.796 0.818 0.83 2.31 0.58
Sick leave  daysc 76 positive
31 negative
0.66 (0.55–0.78) 5.5 0.671 0.581 3.64 10.09 2.52
Presenteeism  daysd 84 positive
28 negative
0.55 (0.44–0.67) 4.5 0.548 0.571 2.84 7.87 1.64
Presenteeism  scored 89 positive
29 negative





1 The type of ICC is not clearly stated in the article. This information 
was known after e-mailing with the last author LHvR.
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In a recent systematic review, the psychometric proper-
ties of eleven work productivity questionnaires were exam-
ined [11]. Data on the retest reliability of absenteeism was 
available for only four questionnaires. However, we cannot 
compare our results with these questionnaires for several 
reasons: no ICC or kappa performed [34–36], type of ICC 
unknown [37, 38], or a different recall period (3 months) 
and calculation of kappa (absenteeism 0 vs. > 0 days) [39].
Despite the importance of absenteeism data as a return to 
work outcome and as a resource for economic evaluations, 
the evidence on the reliability of absenteeism measures is 
remarkably scarce. A possible explanation for this is that 
in several countries researchers can obtain sick leave data 
from social security databases [40], which is a feasible and 
reliable alternative [13]. However, such databases are not 
available for all countries, and another disadvantage is that 
the accuracy of sick leave data from electronic databases is 
Fig. 2  ROC curves of the iPCQ-VR. a Number of working hours per 
week, ROC curve of participants who were on 100% sick leave at T0 
and who reported stable or improved work functioning at T2 (n = 71). 
b Number of sick leave days in preceding 4 weeks, ROC curve of par-
ticipants who were on short-term sick leave at T0 and who reported 
stable or improved work functioning at T2 (n = 107). c Number of 
presenteeism days in preceding 4 weeks, ROC curve of participants 
who scored ‘yes’ on presenteeism at T0 and who reported stable or 
improved work functioning at T2 (n = 112). d Presenteeism score 
(0–10) of preceding 4 weeks, ROC curve of participants who scored 
‘yes’ on presenteeism at T0 and who reported stable or improved 
work functioning at T2 (n = 118). ROC receiver operating characteris-
tic, AUC area under the curve
 Journal of Occupational Rehabilitation
1 3
low for short recall periods (i.e. “acute” sick leave) [12, 13, 
41]. Because the reliability of short term sick leave was also 
low in the present study, this measure warrants improvement 
in future studies.
The ICCs ranging from 0.52 to 0.56 of the presenteeism 
items of the current study are somewhat lower compared 
with a review on the reliability of five at work productivity 
loss questionnaires in patients with rheumatic diseases, with 
single measures ICCs ranging from 0.59 to 0.78 (n = 62–65) 
[10]. The higher ICCs of other studies can be explained by 
the low power (n = 23) and longer recall period (four weeks) 
of the present study. A power of ≥ 50 and a recall period of 
1 week is advocated [12].
Agreement
The observed agreement of the current study was some-
what lower compared with the original study (short-term 
sick leave: 72 vs. 87%, long-term sick leave: 88 vs. 93%, 
and presenteeism: 74 vs. 81%) [18]. This difference can be 
explained through a difference in power (n = 50 vs. n = 79). 
Unfortunately, the original study did not calculate the posi-
tive and/or negative agreement. There is one study known 
which also calculated observed agreement [39], but com-
parison with this study is not possible due to a different 
calculation of kappa (0 vs. > 0 h of absenteeism, presen-
teeism). As there are currently no cut-off scores available 
for the interpretation of positive and negative agreement, 
the information from the 2 × 2 contingency tables (Online 
Appendix 3) can be used by the reader to judge the uptake 
of a questionnaire or a particular item.
Responsiveness
The responsiveness analyses showed that a minimal impor-
tant change of ≥ 1 working hours per week at discharge of 
VR can be used for evaluative purposes for patients who are 
on full sick leave at baseline. A minimal important change of 
5.5 sick leave days per month can be considered for evalua-
tive purposes for patients who are on full sick leave at base-
line. However, this warrants caution because the moderate 
AUC value of 0.66 is below the adequate level of 0.7.
The number of presenteeism days and the presenteeism 
score cannot be used for evaluative purposes because the 
AUCs were too low (0.55 and 0.60). One study assessed the 
responsiveness of five presenteeism scales (ranging from 
0 to 10 or 1–7) [14]. In this study, ROCs and AUCs were 
assessed (and no MICs). The AUCs in this study ranged 
from 0.52 to 0.66, which is similar to that of the current 
study.
TiCP‑VR
The sum of all healthcare visits of the TiCP-VR showed 
sufficient retest reliability and agreement, and can be used 
at group level. However, the single healthcare items of the 
TiCP-VR showed low kappa values and moderate agree-
ment, which can be explained by uneven distributions of 
the 2 × 2 contingency tables (Online Appendix 4). This nega-
tively affects the kappa and agreement values [23]. Further-
more, of four healthcare items (stay in a healthcare setting, 
social worker, insurance physician, home care) it was not 
possible to calculate kappa and agreement measures as none 
of the participants used these services. These items may be 
deleted to increase feasibility.
Medication use showed substantial retest reliability and 
adequate agreement. This item can be used at group level. 
In contrast, pain-specific medication use scored poor retest 
reliability and agreement, and this item cannot be used at 
group level and needs to be refined. Unfortunately, due to a 
technical error we were not able to assess the dosage, fre-
quency and name of the consumed pain medications.
Table 7  Mean change scores of 
iPCQ-VR
a If presenteeism in the preceding 4 weeks was answered no on T2, presenteeism days was set at zero (0)
b If presenteeism in the preceding 4 weeks was answered no on T2, presenteeism score was set at ten (10)
Working hours Sick leave days Presenteeism  daysa Presenteeism  scoreb
Baseline T0
 Mean (SD) 0 13.1 (7.0) 11.8 (6.6) 5.3 (2.3)
 Minimum–maximum 0–0 0–31 2–28 0–10
 N 83 123 130 136
Discharge T2
 Mean (SD) 8.7 (10.7) 4.1 (7.4) 5.2 (6.0) 7.3 (2.5)
 Minimum–maximum 0–40 0–31 0–20 0–10
 N 81 127 129 131
Mean change (SD) − 8.7 (10.7) 9.2 (9.0) 6.4 (7.4) − 2.02 (3.2)
95% CI of mean change − 11.08 to − 6.35 7.58–10.85 5.08–7.72 − 2.58 to − 1.46
N 81 119 124 131
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The observed agreement of the current study is in line 
with the observed agreement from the original study [18]. 
Comparison on retest reliability (ICC values) with the origi-
nal study is not possible as they used a different type of ICC.
Strengths and Limitations
A strength of this study is that we included a sample of 
patients with chronic musculoskeletal pain who were 
referred to six VR centers in the Netherlands. This increases 
the clinical utility of this study. Second, we have extensively 
investigated both PROMS and we provided all 2 × 2 contin-
gency tables (Online Appendices 3, 4), as recommended 
[29].
Our results should be generalized cautiously as our study 
has some limitations that must be addressed. First, an inclu-
sion criteria for this study was that participants should be 
on sick leave (part-time or full-time) at baseline. However, 
14% of study sample one and 8.5% of study sample two were 
not at sick leave at baseline but full-time at work. This has 
resulted in lower samples for the performed analyses, which 
probably negatively affected the results on sick leave and 
presenteeism. Second, we applied anchor items at measure-
ment 2 to detect stable and unstable (i.e. changed) samples 
of participants. For working status and the number of hours 
working per week, this resulted in better results on retest 
reliability in the stable group of participants. However, for 
the other items of the iPCQ-VR, such as short- and long-
term sick leave and presenteeism, the results remained the 
same. Remarkably, the healthcare items of the TiCP-VR 
showed in general lower retest reliability (lower kappa val-
ues) in the stable sample compared with the unstable sample. 
Therefore, the anchor items applied in this study warrant 
refinement.
Third, we assessed presenteeism with a time interval of 2 
weeks. This is in line with similar studies [10]. Presenteeism 
may be unstable; it can fluctuate between days and weeks. 
Sim et al. [23] stated that for the time interval in retest reli-
ability studies ‘the stability of the attribute being rated is 
crucial to the period between repeated ratings’. We advise 
using a shorter time interval (for example 2 days) with con-
trol for stability to increase retest reliability in future studies.
The fourth and final limitation is the second measurement 
point in the responsiveness analysis (Fig. 1). Due to feasibil-
ity/technical reasons, patients received these questionnaires 
14-weeks after the start of their 15-week VR program. In 
clinical practice, this is 1 week before the real discharge 
date and in some patients, this might even be worse if they 
were on holiday during the intervention period or had an 
extension of their training period. We suppose that this flaw 
yields an underestimation on the responsiveness measures 
in this study, because when people are in rehabilitation they 
cannot be at work.
Clinical Recommendations
We recommend using the working status and number of 
working hours per week items of the iPCQ-VR to provide 
an estimation of short-term sick leave, which is in line with 
the majority of the return to work intervention studies, which 
use an estimate of lost time from work as their primary RTW 
outcome [42, 43]. A minimal important change of ≥ 1 work-
ing hours per week can be used for evaluative purposes for 
patients who are on full sick leave at baseline. Furthermore, 
a minimal important change of 5.5 sick leave days per month 
can be considered for patients who are on full sick leave at 
baseline. However, this warrants caution due to the moderate 
AUC of 0.66. The items of the iPCQ-VR should not be used 
for the assessment of presenteeism.
The sum of all healthcare utilization items of the TiCP-
VR can be used at group level, but the single items needs 
further investigation. The generic item on medication use 
can be used at group level, but the pain-specific medication 
use item warrants improvement.
Conclusion
The iPCQ-VR showed good measurement properties on 
working status, number of hours working per week and 
long-term sick leave, and low measurement properties 
on short-term sick leave and presenteeism. The TiCP-VR 
showed adequate reliability on total healthcare utilization 
and medication use, but showed low measurement properties 
on the single healthcare utilization items.
Funding No commercial sponsorship was involved in the design and 
conduction of the study.
Compliance with Ethical Standards 
Conflict of interest Author TB, author JvV, author CvB, author MR, 
and author MFD declare that they have no conflict of interest.
Ethical Approval All procedures performed were in accordance with 
the ethical standards of the institutional research committee and with 
the 1964 Helsinki declaration and its later amendments or comparable 
ethical standards. The Medical Ethical Committee of the Academic 
Medical Center, Amsterdam, the Netherlands, authorized this study 
and decided that a full application was not required.
Informed Consent Informed consent was obtained from all individual 
participants included in the study.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://creat iveco 
mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
 Journal of Occupational Rehabilitation
1 3
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
 1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Sur-
vey of chronic pain in Europe: prevalence, impact on daily life, 
and treatment. Eur J Pain. 2006;10(4):287–333.
 2. de Vroome EM, Uegaki K, van der Ploeg CP, Treutlein DB, 
Steenbeek R, de Weerd M, et al. Burden of sickness absence due 
to chronic disease in the Dutch workforce from 2007 to 2011. J 
Occup Rehabil. 2015;25(4):675–684.
 3. van Dongen JM, van Wier MF, Tompa E, Bongers PM, van der 
Beek AJ, van Tulder MW, et al. Trial-based economic evaluations 
in occupational health: principles, methods, and recommenda-
tions. J Occup Environ Med. 2014;56(6):563–572.
 4. Hakkaart-van Roijen LTS, Bouwmans C. Manual for cost 
research. Methods and standard cost prices for economic evalu-
ations in health care. Rotterdam; 2010.
 5. Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Mof-
fett J, Kovacs F, et al. Chapter 4. European guidelines for the 
management of chronic nonspecific low back pain. Eur Spine 
J. 2006;15(Suppl 2):S192–S300.
 6. Escorpizo R, Brage S, Homa D, Stucki G. Handbook of voca-
tional rehabilitation and disability evaluation. Cham: Springer; 
2014. pp. 3–10
 7. Waddell G, Burton AK, Kendall NAS. Vocational rehabilitation. 
What works, for whom, and when? 2013.
 8. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ. The 
routine use of patient reported outcome measures in healthcare 
settings. BMJ. 2010;340:c186. https ://doi.org/10.1136/bmj.
c186.
 9. Krol M, Brouwer W, Rutten F. Productivity costs in eco-
nomic evaluations: past, present, future. Pharmacoeconomics. 
2013;31(7):537–549.
 10. Leggett S, van der Zee-Neuen A, Boonen A, Beaton DE, 
Bojinca M, Bosworth A, et al. Test–retest reliability and cor-
relations of 5 global measures addressing at-work produc-
tivity loss in patients with rheumatic diseases. J Rheumatol. 
2016;43(2):433–439.
 11. Tang K. Estimating productivity costs in health economic eval-
uations: a review of instruments and psychometric evidence. 
Pharmacoeconomics. 2015;33(1):31–48.
 12. Zhang W, Bansback N, Anis AH. Measuring and valuing pro-
ductivity loss due to poor health: a critical review. Soc Sci Med. 
2011;72(2):185–192.
 13. Ostelo RW, de Vet HC. Clinically important outcomes in low 
back pain. Best Pract Res Clin Rheumatol. 2005;19(4):593–607.
 14. Beaton DE, Tang K, Gignac MA, Lacaille D, Badley EM, Anis 
AH, et al. Reliability, validity, and responsiveness of five at-
work productivity measures in patients with rheumatoid arthritis 
or osteoarthritis. Arthritis Care Res. 2010;62(1):28–37.
 15. Bouwmans C, Krol M, Severens H, Koopmanschap M, Brou-
wer W, Hakkaart-van Roijen L. The iMTA productivity cost 
questionnaire: a standardized instrument for measuring and 
valuing health-related productivity losses. Value Health. 
2015;18(6):753–758.
 16. Krol M, Brouwer W. How to estimate productivity costs in eco-
nomic evaluations. Pharmacoeconomics. 2014;32(4):335–344.
 17. Bouwmans C, Hakkaart-van Roijen L, Koopmanschap M, Krol 
M, Severens H, Brouwer W. Manual of the iMTA productivity 
cost questionnaire (iPCQ). Rotterdam: iMTA, Erasmus Univer-
sity Rotterdam; 2013.
 18. Bouwmans C, De Jong K, Timman R, Zijlstra-Vlasveld M, 
Van der Feltz-Cornelis C, Tan Swan S, et al. Feasibility, reli-
ability and validity of a questionnaire on healthcare consump-
tion and productivity loss in patients with a psychiatric disor-
der (TiC-P). BMC Health Serv Res. 2013;13:217. https ://doi.
org/10.1186/1472-6963-13-217.
 19. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, 
Knol DL, et al. The COSMIN checklist for assessing the meth-
odological quality of studies on measurement properties of 
health status measurement instruments: an international Delphi 
study. Qual Life Res. 2010;19(4):539–549.
 20. Reneman MF, Beemster TT, Edelaar MJ, van Velzen JM, van 
Bennekom C, Escorpizo R. Towards an ICF- and IMMPACT-
based pain vocational rehabilitation core set in the Netherlands. 
J Occup Rehabil. 2013;23(4):576–584.
 21. Weir JP. Quantifying test–retest reliability using the intraclass 
correlation coefficient and the SEM. J Strength Cond Res. 
2005;19(1):231–240.
 22. Nunnally JC. Psychometric theory. 2nd ed. New York: McGraw-
Hill; 1978.
 23. Sim J, Wright CC. The kappa statistic in reliability studies: 
use, interpretation, and sample size requirements. Phys Ther. 
2005;85(3):257–268.
 24. De Vet HCW, Terwee CB, Knol DL, Mokkink LB. Measurement 
in medicine. Cambridge: Cambridge University Press 2011.
 25. Warrens M. Weighted Kappas for 3 × 3 Tables. J Probab Stat. 
2013;2013:325831. https ://doi.org/10.1155/2013/32583 1.
 26. Vanbelle S. A new interpretation of the weighted Kappa coef-
ficients. Psychometrika. 2016;81(2):399–410.
 27. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, 
Dekker J, et al. Quality criteria were proposed for measurement 
properties of health status questionnaires. J Clin Epidemiol. 
2007;60(1):34–42.
 28. Kievit AJ, Kuijer PP, Kievit RA, Sierevelt IN, Blankevoort 
L, Frings-Dresen MH. A reliable, valid and responsive ques-
tionnaire to score the impact of knee complaints on work fol-
lowing total knee arthroplasty: the WORQ. J Arthroplasty. 
2014;29(6):1169–1175.
 29. de Vet HC, Mokkink LB, Terwee CB, Hoekstra OS, Knol 
DL. Clinicians are right not to like Cohen’s kappa. BMJ. 
2013;346:f2125. https ://doi.org/10.1136/bmj.f2125 .
 30. Soer R, Reneman MF, Vroomen PC, Stegeman P, Coppes MH. 
Responsiveness and minimal clinically important change of the 
pain disability index in patients with chronic back pain. Spine. 
2012;37(8):711–715.
 31. Deyo RA, Centor RM. Assessing the responsiveness of func-
tional scales to clinical change: an analogy to diagnostic test 
performance. J Chronic Dis. 1986;39(11):897–906.
 32. Accessed 20 Jun 2017; Available from: http://vassa rstat s.net/
kappa .html.
 33. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, 
de Vet HC. Rating the methodological quality in systematic 
reviews of studies on measurement properties: a scoring system 
for the COSMIN checklist. Qual Life Res. 2012;21(4):651–657.
 34. Kessler RC, Ames M, Hymel PA, Loeppke R, McKenas DK, 
Richling DE, et  al. Using the World Health Organization 
Health and work performance questionnaire (HPQ) to evaluate 
the indirect workplace costs of illness. J Occup Environ Med. 
2004;46(6 Suppl):S23–S37.
 35. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health 
and productivity cost burden of the “top 10” physical and men-
tal health conditions affecting six large U.S. employers in 1999. 
J Occup Environ Med. 2003;45(1):5–14.
 36. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproduc-
ibility of a work productivity and activity impairment instru-
ment. Pharmacoeconomics. 1993;4(5):353–365.
Journal of Occupational Rehabilitation 
1 3
 37. Ariza-Ariza R, Hernandez-Cruz B, Navarro-Compan V, 
Leyva Pardo C, Juanola X, Navarro-Sarabia F. A compari-
son of telephone and paper self-completed questionnaires 
of main patient-related outcome measures in patients with 
ankylosing spondylitis and psoriatic arthritis. Rheumatol Int. 
2013;33(11):2731–2736.
 38. Bushnell DM, Reilly MC, Galani C, Martin ML, Ricci JF, Pat-
rick DL, et al. Validation of electronic data capture of the irri-
table bowel syndrome–quality of life measure, the work produc-
tivity and activity impairment questionnaire for irritable bowel 
syndrome and the EuroQol. Value Health. 2006;9(2):98–105.
 39. Zhang W, Bansback N, Kopec J, Anis AH. Measuring time 
input loss among patients with rheumatoid arthritis: validity 
and reliability of the valuation of lost productivity question-
naire. J Occup Environ Med. 2011;53(5):530–536.
 40. Anema JR, Schellart AJ, Cassidy JD, Loisel P, Veerman TJ, van 
der Beek AJ. Can cross country differences in return-to-work 
after chronic occupational back pain be explained? An explora-
tory analysis on disability policies in a six country cohort study. 
J Occup Rehabil. 2009;19(4):419–426.
 41. Pole JD, Franche RL, Hogg-Johnson S, Vidmar M, Krause N. 
Duration of work disability: a comparison of self-report and 
administrative data. Am J Ind Med. 2006;49(5):394–401.
 42. Cullen KL, Irvin E, Collie A, Clay F, Gensby U, Jennings PA, 
et al. Effectiveness of workplace interventions in return-to-work 
for musculoskeletal, pain-related and mental health conditions: 
an update of the evidence and messages for practitioners. J 
Occup Rehabil. 2018;28(1):1–15. https ://doi.org/10.1007/s1092 
6-016-9690-x.
 43. Vogel AP, Barker SJ, Young AE, Ruseckaite R, Collie A. What is 
return to work? An investigation into the quantification of return 
to work. Int Arch Occup Environ Health. 2011;84(6):675–682.
